DAVIDE CAMPARI-MILANO N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.476 EUR | +0.98% |
|
+5.62% | -7.23% |
| Apr. 19 | Campari inaugurates new Aperol bottling line in Novi Ligure | AN |
| Apr. 17 | Traders ignore Powell; Popolare Sondrio bullish | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With a 2024 P/E ratio at 27.45 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 4.27 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Distillers & Wineries
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -7.23% | 12.02B | B | ||
| -4.60% | 290B | C+ | ||
| +1.85% | 77.75B | C+ | ||
| +3.53% | 40.85B | D+ | ||
| -2.08% | 36.24B | C+ | ||
| -13.15% | 19.99B | C+ | ||
| +8.15% | 15.98B | C | ||
| +0.48% | 9.76B | B- | ||
| +14.15% | 9.65B | C- | ||
| -7.83% | 6.85B | D+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CPR Stock
- Ratings Davide Campari-Milano N.V.
